Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Xilio Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Restricted Stock Units | 66.5K | $681K | $10.24 | Jan 1, 2024 | Direct |
Xilio Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Stock Option (right to buy) | 59.3K | May 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
XLO | Xilio Therapeutics, Inc. | May 1, 2024 | 1 | $0 | 4 | May 3, 2024 | CHIEF MEDICAL OFFICER |
XLO | Xilio Therapeutics, Inc. | Jan 1, 2024 | 1 | $0 | 4 | Jan 3, 2024 | CHIEF MEDICAL OFFICER |
XLO | Xilio Therapeutics, Inc. | Sep 5, 2023 | 1 | $0 | 4 | Sep 7, 2023 | Chief Medical Officer |
XLO | Xilio Therapeutics, Inc. | Sep 5, 2023 | 0 | $0 | 3 | Sep 7, 2023 | Chief Medical Officer |